INFILBRAY
Live / Allowed — Publication / registration review complete (as of 08 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 27 Apr 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99788369
- Mark type
- Design + words
- Filed
- 27 Apr 2026
- Published for opposition
- 29 Sept 2026
- Attorney of record
- Alexandra Kochian
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of cardiovascular diseases and diseases of the central nervous system; Pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; Pharmaceutical preparations for the treatment of rare diseases, namely, lysosomal storage disorders and autosomal dominant polycystic kidney disease; Pharmaceutical preparations for the treatment and prevention of infectious diseases, namely, viral and bacterial infections
Owner
- Genzyme Corporation, Cambridge, MA, US
Prosecution history
- 01 Sept 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 01 Sept 2026 — ASSIGNED TO EXAMINER
- 31 Aug 2026 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 31 Aug 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 27 Apr 2026 — APPLICATION FILING RECEIPT MAILED
- 27 Apr 2026 — NEW APPLICATION ENTERED